Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
Sony
SONY
$140B
| $8.76M | ﹤0.01% |
644,000
-1,024,500
| -61% | -$12.8M |
|
1502
Planet Fitness
PLNT
$3.69B
| $8.75M | ﹤0.01% |
117,233
-185,470
| -61% | -$12.5M |
|
1503
PUT
Tyson Foods
TSN
$20.3B
| $8.75M | ﹤0.01% |
96,100
+81,700
| +567% | +$7.03M |
|
1504
PUT
Prudential Financial
PRU
$41.9B
| $8.75M | ﹤0.01% |
93,300
+2,900
| +3% | +$266K |
|
|
IMMU
1505
DELISTED
Immunomedics Inc
IMMU
| $8.74M | ﹤0.01% |
412,996
+157,743
| +62% | +$2.78M |
|
1506
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $8.74M | ﹤0.01% |
351,065
-117,472
| -25% | -$2.85M |
|
1507
Sabesp
SBS
$18.3B
| $8.74M | ﹤0.01% |
2,993,908
-1,054,313
| -26% | -$2.71M |
|
1508
Oshkosh
OSK
$9.56B
| $8.7M | ﹤0.01% |
91,880
-72,012
| -44% | -$6.21M |
|
|
BPMC
1509
DELISTED
Blueprint Medicines
BPMC
| $8.69M | ﹤0.01% |
108,528
+80,468
| +287% | +$6.02M |
|
1510
CALL
Qiagen
QGEN
$9.06B
| $8.69M | ﹤0.01% |
+242,365
| New | +$9.01M |
|
1511
CALL
BlackBerry
BB
$5.28B
| $8.68M | ﹤0.01% |
1,351,600
+81,200
| +6% | +$446K |
|
1512
PUT
Enbridge
ENB
$113B
| $8.67M | ﹤0.01% |
218,100
-25,700
| -11% | -$960K |
|
1513
SS&C Technologies
SSNC
$18.6B
| $8.66M | ﹤0.01% |
141,112
+87,903
| +165% | +$4.93M |
|
1514
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$20.1B
| $8.64M | ﹤0.01% |
746,582
+165,122
| +28% | +$1.6M |
|
1515
PUT
CSX Corp
CSX
$93B
| $8.61M | ﹤0.01% |
357,000
+217,200
| +155% | +$5.14M |
|
|
HDS
1516
DELISTED
HD Supply Holdings, Inc.
HDS
| $8.6M | ﹤0.01% |
213,831
-237,649
| -53% | -$9.45M |
|
1517
Targa Resources
TRGP
$56.9B
| $8.6M | ﹤0.01% |
210,613
-43,487
| -17% | -$1.69M |
|
|
BBBY
1518
DELISTED
Bed Bath & Beyond Inc
BBBY
| $8.6M | ﹤0.01% |
496,840
-86,259
| -15% | -$1.21M |
|
|
JJG
1519
DELISTED
iPath Series B Bloomberg Grains Subindex Total ReturnSM ETN
JJG
| $8.58M | ﹤0.01% |
186,000
-50,000
| -21% | -$2.24M |
|
1520
Factset
FDS
$10.2B
| $8.58M | ﹤0.01% |
31,977
+18,468
| +137% | +$4.74M |
|
1521
MongoDB
MDB
$33.5B
| $8.56M | ﹤0.01% |
65,064
+6,576
| +11% | +$863K |
|
1522
PUT
McKesson
MCK
$103B
| $8.56M | ﹤0.01% |
61,900
+47,200
| +321% | +$6.67M |
|
1523
CrowdStrike
CRWD
$229B
| $8.55M | ﹤0.01% |
685,660
+572,036
| +503% | +$7.51M |
|
1524
CALL
Macy's
M
$6.69B
| $8.54M | ﹤0.01% |
502,300
-63,400
| -11% | -$992K |
|
|
CIM
1525
Chimera Investment
CIM
$976M
| $8.53M | ﹤0.01% |
138,217
-22,537
| -14% | -$1.37M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.